Erythropoietin administration during primary treatment for locally advanced cervical carcinoma is associated with poor response to radiation (Q79160426)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 September 2006
edit
Language Label Description Also known as
English
Erythropoietin administration during primary treatment for locally advanced cervical carcinoma is associated with poor response to radiation
scientific article published on 01 September 2006

    Statements

    Erythropoietin administration during primary treatment for locally advanced cervical carcinoma is associated with poor response to radiation (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit